+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Oral Cancer Drug"

Oral Cancer Treatment Global Market Report 2024 - Product Thumbnail Image

Oral Cancer Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
Intratumoral Cancer Therapies Global Market Report 2024 - Product Thumbnail Image

Intratumoral Cancer Therapies Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Lip and Oral Cavity Cancer - Epidemiology Forecast to 2032 - Product Thumbnail Image

Lip and Oral Cavity Cancer - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Global Oral Cancer Therapeutics Market 2022-2026 - Product Thumbnail Image

Global Oral Cancer Therapeutics Market 2022-2026

  • Report
  • March 2022
  • 120 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
From
From
Loading Indicator

The Oral Cancer Drug market is a subset of the larger Oncology Drugs market. Oral cancer drugs are used to treat cancers of the mouth, throat, and other areas of the head and neck. These drugs are typically administered orally, either as a pill or a liquid, and can be used to treat both early and advanced stages of cancer. Common oral cancer drugs include chemotherapy, targeted therapy, and immunotherapy. Chemotherapy drugs are used to kill cancer cells, while targeted therapy drugs are designed to target specific cancer cells. Immunotherapy drugs are used to boost the body’s natural immune system to fight cancer. Some companies in the Oral Cancer Drug market include Bristol-Myers Squibb, Merck, Pfizer, AstraZeneca, and Novartis. Show Less Read more